Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab

IMPORTANCE: Understanding adoption of new cancer therapies may help identify opportunities to increase use for high-value indications. OBJECTIVE: To determine whether use of bevacizumab in 2005 to 2006 by oncologists’ peers was associated with greater bevacizumab use among oncologists in 2007 to 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Keating, Nancy L., O’Malley, A. James, Onnela, Jukka-Pekka, Gray, Stacy W., Landon, Bruce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991243/
https://www.ncbi.nlm.nih.gov/pubmed/31899533
http://dx.doi.org/10.1001/jamanetworkopen.2019.18586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991243/
https://www.ncbi.nlm.nih.gov/pubmed/31899533
http://dx.doi.org/10.1001/jamanetworkopen.2019.18586

Ejemplares similares